Current Surgical Raises $3.2M in Seed Funding
- Current Surgical, a Washington, DC-based medtech company, raised $3.2m in seed funding
- The round was led by True Ventures, with participation from 1517 Fund and SciFounders
- The company intends to use the funds to accelerate growth, expand operations and its business reach
- CurrentSurgical is a preclinical-stage company enabling a type of hybrid therapies through the development of surgical tools to allow doctors to precisely treat currently untreatable solid tumors
- CurrentSurgical gives doctors a precision guided needle that can accurately destroy tumors, without harming surrounding healthy tissue, anywhere in the body
